Christine Schmid-Tannwald to Diffusion Magnetic Resonance Imaging
This is a "connection" page, showing publications Christine Schmid-Tannwald has written about Diffusion Magnetic Resonance Imaging.
Connection Strength
3.881
-
The role of diffusion-weighted MRI in assessment of inflammatory bowel disease. Abdom Radiol (NY). 2016 08; 41(8):1484-94.
Score: 0.477
-
DW-MRI of liver lesions: can a single ADC-value represent the entire lesion? Clin Radiol. 2014 May; 69(5):492-8.
Score: 0.404
-
Diffusion-weighted MRI of metastatic liver lesions: is there a difference between hypervascular and hypovascular metastases? Acta Radiol. 2014 Jun; 55(5):515-23.
Score: 0.390
-
Diffusion-weighted MR imaging of focal liver lesions in the left and right lobes: is there a difference in ADC values? Acad Radiol. 2013 Apr; 20(4):440-5.
Score: 0.379
-
Comparison of abdominal MRI with diffusion-weighted imaging to 68Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreas. Eur J Nucl Med Mol Imaging. 2013 Jun; 40(6):897-907.
Score: 0.377
-
Diffusion-weighted MRI of the abdomen: current value in clinical routine. J Magn Reson Imaging. 2013 Jan; 37(1):35-47.
Score: 0.372
-
Diffusion-weighted MRI: role in detecting abdominopelvic internal fistulas and sinus tracts. J Magn Reson Imaging. 2012 Jan; 35(1):125-31.
Score: 0.341
-
Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases. Radiol Oncol. 2024 Mar 01; 58(1):33-42.
Score: 0.201
-
Diffusion-weighted imaging in Crohn's disease. Radiologie (Heidelb). 2023 Nov; 63(Suppl 2):27-33.
Score: 0.194
-
Apparent diffusion coefficients (ADC) in response assessment of transarterial radioembolization (TARE) for liver metastases of neuroendocrine tumors (NET): a feasibility study. Acta Radiol. 2022 Jul; 63(7):877-888.
Score: 0.168
-
Diffusion-weighted MRI Before and After Robotic Radiosurgery (Cyberknife®) in Primary and Secondary Liver Malignancies: A Pilot Study. Technol Cancer Res Treat. 2015 Apr; 14(2):191-9.
Score: 0.106
-
Role of diffusion-weighted MRI in differentiation of hepatic abscesses from non-infected fluid collections. Clin Radiol. 2014 Jul; 69(7):687-94.
Score: 0.101
-
Apparent diffusion coefficient for prostate cancer imaging: impact of B values. AJR Am J Roentgenol. 2014 Mar; 202(3):W247-53.
Score: 0.101
-
Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study. Radiology. 2013 Jun; 267(3):787-96.
Score: 0.094
-
Diffusion-weighted MR imaging of abdominopelvic abscesses. Emerg Radiol. 2011 Dec; 18(6):515-24.
Score: 0.084
-
Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma. Acta Radiol. 2024 Jan; 65(1):14-22.
Score: 0.047
-
Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging. Radiology. 2013 Jun; 267(3):797-806.
Score: 0.024
-
Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. AJR Am J Roentgenol. 2011 Dec; 197(6):1382-90.
Score: 0.022